- Home
- URG vs HQL Comparison
URG vs HQL Comparison
Compare URG & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- HQL
- Stock Information
- Founded
- URG 2004
- HQL 1992
- Country
- URG United States
- HQL United States
- Employees
- URG N/A
- HQL N/A
- Industry
- URG Precious Metals
- HQL Investment Managers
- Sector
- URG Basic Materials
- HQL Finance
- Exchange
- URG Nasdaq
- HQL Nasdaq
- Market Cap
- URG 342.2M
- HQL 409.2M
- IPO Year
- URG N/A
- HQL N/A
- Fundamental
- Price
- URG $1.20
- HQL $15.20
- Analyst Decision
- URG Strong Buy
- HQL
- Analyst Count
- URG 2
- HQL 0
- Target Price
- URG $2.45
- HQL N/A
- AVG Volume (30 Days)
- URG 3.4M
- HQL 120.9K
- Earning Date
- URG 11-06-2024
- HQL 01-01-0001
- Dividend Yield
- URG N/A
- HQL 11.56%
- EPS Growth
- URG N/A
- HQL N/A
- EPS
- URG N/A
- HQL 0.79
- Revenue
- URG $16,494,000.00
- HQL N/A
- Revenue This Year
- URG $89.01
- HQL N/A
- Revenue Next Year
- URG $81.36
- HQL N/A
- P/E Ratio
- URG N/A
- HQL $17.08
- Revenue Growth
- URG 34.78
- HQL N/A
- 52 Week Low
- URG $0.96
- HQL $11.34
- 52 Week High
- URG $2.01
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- URG 44.63
- HQL 58.39
- Support Level
- URG $1.25
- HQL $14.51
- Resistance Level
- URG $1.35
- HQL $15.10
- Average True Range (ATR)
- URG 0.06
- HQL 0.18
- MACD
- URG -0.01
- HQL 0.02
- Stochastic Oscillator
- URG 11.11
- HQL 94.52
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.